- Home
- AXSM vs ACIW Comparison
AXSM vs ACIW Comparison
Compare AXSM & ACIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | ACIW |
|---|---|---|
| Founded | 2012 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 5.0B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AXSM | ACIW |
|---|---|---|
| Price | $148.59 | $48.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 3 |
| Target Price | ★ $176.00 | $60.00 |
| AVG Volume (30 Days) | 477.6K | ★ 713.9K |
| Earning Date | 02-17-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.89 |
| EPS | N/A | ★ 2.47 |
| Revenue | $561,263,000.00 | ★ $1,731,220,000.00 |
| Revenue This Year | $66.40 | $11.46 |
| Revenue Next Year | $56.13 | $2.25 |
| P/E Ratio | ★ N/A | $19.64 |
| Revenue Growth | ★ 65.83 | 7.01 |
| 52 Week Low | $75.56 | $40.45 |
| 52 Week High | $158.57 | $58.14 |
Technical Indicators
Market Signals| Indicator | AXSM | ACIW |
|---|---|---|
| Relative Strength Index (RSI) | 50.89 | 52.91 |
| Support Level | $152.41 | $47.92 |
| Resistance Level | $158.56 | $49.10 |
| Average True Range (ATR) | 4.09 | 1.04 |
| MACD | -0.44 | 0.17 |
| Stochastic Oscillator | 29.93 | 70.74 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.